Influence of chromosome 22q11.2 microdeletion on postoperative calcium level after cardiac-correction surgery

Pediatric Cardiology

Volumn 32, Issue 7, 2011, Pages 904-909

  Shen, Li ^a,b   Gu, Haitao ^b,c   Wang, Dongjing ^d   Yang, Chi ^a,d   Xu, Zhengfeng ^b   Jing, Hua ^e   Jiang, Yongzhong ^b   Ding, Yibing ^a   Hou, Huacheng ^a   Ge, Zhijuan ^a   Chen, Shilin ^d,e   Mo, Xuming ^b   Yi, Long ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^e NANJING UNIVERSITY   (China)

Author keywords

Cardiac surgery; Chromosome 22q11.2 microdeletion; Congenital heart defects; Hypocalcaemia

Indexed keywords

CALCIUM;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CHILD; CHROMOSOME DELETION 22Q11; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPARATIVE STUDY; CONGENITAL HEART MALFORMATION; FEMALE; HEART SURGERY; HUMAN; HYPOCALCEMIA; IMMUNE DEFICIENCY; MALE; MEDICAL DOCUMENTATION; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; BLOOD; CHINA; CHROMOSOME 22; CHROMOSOME DELETION; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENETICS; INCIDENCE; INFANT; NEWBORN; TIME;

CALCIUM; CARDIAC SURGICAL PROCEDURES; CHINA; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HUMANS; HYPOCALCEMIA; IN SITU HYBRIDIZATION, FLUORESCENCE; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84859703002     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-011-0012-y     Document Type: Article

References (22)

1. Anaclerio S, Di CV, Michielon G, Digilio MC, Formigari R, Picchio FM et al (2004) Conotruncal heart defects: impact of genetic syndromes on immediate operative mortality. Ital Heart J 5:624-628
2. Brauner R, de Le Harivel GA, Kindermans C, Le BJ, Prieur M, Lyonnet S et al (2003) Parathyroid function and growth in 22q11.2 deletion syndrome. J Pediatr 142:504-508
3. Conley ME, Beckwith JB, Mancer JF, Tenckhoff L (1979) The spectrum of the DiGeorge syndrome. J Pediatr 94:883-890
4. Cuneo BF, Langman CB, Ilbawi MN, Ramakrishnan V, Cutilletta A, Driscoll DA (1996) Latent hypoparathyroidism in children with conotruncal cardiac defects. Circulation 93:1702-1708
5. Cuneo BF, Driscoll DA, Gidding SS, Langman CB (1997) Evolution of latent hypoparathyroidism in familial 22q11 deletion syndrome. Am J Med Genet 69:50-55
6. de Andrade SA, Salles JM, Soares JM, de Moraes GM, Carvalho JR, Rocha PR (2010) Course of ionized calcium after thyroidectomy. World J Surg 34:987-992
7. DiGeorge AM (1965) Discussions on a new concept of the cellular basis of immunity. J Pediatr 67:907-908
8. Donald-McGinn DM, Kirschner R, Goldmuntz E, Sullivan K, Eicher P, Gerdes M et al (1999) The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns 10:11-24
9. Dyke PC, Yates AR, Cua CL, Hoffman TM, Hayes J, Feltes TF et al (2007) Increased calcium supplementation is associated with morbidity and mortality in the infant postoperative cardiac patient. Pediatr Crit Care Med 8:254-257
10. Formigari R, Michielon G, Digilio MC, Piacentini G, Carotti A, Giardini A et al (2009) Genetic syndromes and congenital heart defects: How is surgical management affected? Eur J Cardiothorac Surg 35:606-614
11. Goodship J, Cross I, LiLing J, Wren C (1998) A population study of chromosome 22q11 deletions in infancy. Arch Dis Child 79:348-351
12. Jacobs JP (2008) Introduction - databases and the assessment of complications associated with the treatment of patients with congenital cardiac disease. Cardiol Young 18(Suppl 2):1-37
13. Kapadia CR, Kim YE, Donald-McGinn DM, Zackai EH, Katz LE (2008) Parathyroid hormone reserve in 22q11.2 deletion syndrome. Genet Med 10:224-228
14. Kobrynski LJ, Sullivan KE (2007) Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 370:1443-1452
15. Maalouf NM, Sakhaee K, Odvina CV (2004) A case of chromosome 22q11 deletion syndrome diagnosed in a 32-year-old man with hypoparathyroidism. J Clin Endocrinol Metab 89:4817-4820
16. Michielon G, Marino B, Formigari R, Gargiulo G, Picchio F, Digilio MC et al (2006) Genetic syndromes and outcome after surgical correction of tetralogy of Fallot. Ann Thorac Surg 81:968-975
17. Mussai FJ, Cunningham LC, Rezvani G, Stratakis CA, Reynolds JC, Nesterova G et al (2008) Hypocalcemia in a patient with osteosarcoma and 22q11.2 deletion syndrome. J Pediatr Hematol Oncol 30:612-617
18. Reddy VM, McElhinney DB, Amin Z, Moore P, Parry AJ, Teitel DF et al (2000) Early and intermediate outcomes after repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries: experience with 85 patients. Circulation 101:1826-1832
19. Robertie PG, Butterworth JF, Royster RL, Prielipp RC, Dudas L, Black KW et al (1991) Normal parathyroid hormone responses to hypocalcemia during cardiopulmonary bypass. Anesthesiology 75:43-48
20. Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Seidel H et al (1997) Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 34:798-804
21. Taylor SC, Morris G, Wilson D, Davies SJ, Gregory JW (2003) Hypoparathyroidism and 22q11 deletion syndrome. Arch Dis Child 88:520-522
22. Yang C, Shen L, Xu Z, Wu X, Mo X, Zhang J, Wang D et al (2009) A novel competitive fluorescent multiplex STR polymorphism assay for rapid, reliable and single-tube screening of 22q11.2 copy-number aberrations. Electrophoresis 30:465-471